株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

疥癬治療の世界市場:投薬経路別 (経口、局所)・治療薬別 (軟膏、配合剤)・地域別 (欧州、アジア太平洋地域、北米など) の将来予測

Scabies Treatment Market: By Administration (Oral, Topical) By Medication (Ointment, Combinational Medicine) & By Geography (Europe, Asia Pacific, North America, Rest of the World)-Forecast 2019-2024

発行 IndustryARC 商品コード 422464
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.97円で換算しております。
Back to Top
疥癬治療の世界市場:投薬経路別 (経口、局所)・治療薬別 (軟膏、配合剤)・地域別 (欧州、アジア太平洋地域、北米など) の将来予測 Scabies Treatment Market: By Administration (Oral, Topical) By Medication (Ointment, Combinational Medicine) & By Geography (Europe, Asia Pacific, North America, Rest of the World)-Forecast 2019-2024
出版日: 2018年12月12日 ページ情報: 英文
概要

当レポートでは、世界の疥癬治療薬の市場について分析し、疾患の概要や全体的な市場構造、主な市場促進・抑制要因、投薬経路別・治療薬の種類別・地域別の市場動向見通し (今後6年間分)、市場競争の概況、昨今の資本取引・戦略展開の動き、主要企業のプロファイルなどについて調査・推計しております。

第1章 疥癬治療:市場概要

第2章 エグゼクティブ・サマリー

第3章 市場環境

  • 市場シェア分析
  • 比較分析
  • 製品の相互比較
  • エンドユーザーのプロファイル
  • 上位5社の財務分析

第4章 疥癬治療市場の影響要因

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 課題
  • ポーターのファイブフォース分析

第5章 疥癬治療市場:戦略分析

  • バリューチェーン分析
  • 価格動向分析
  • 市場機会の分析
  • 製品/市場のライフサイクル分析
  • サプライヤー・流通業者

第6章 疥癬治療市場:投薬経路別

  • 経口薬
  • 局所投与

第7章 疥癬治療市場:治療薬の種類別

  • 軟膏
    • ジェル
    • クリーム
    • ローション
  • 配合剤
    • ペルメトリン・クリーム
    • 安息香酸ベンジル・ローション
    • 硫黄軟膏
    • クロタミトン・クリーム
    • リンデン・ローション
  • その他の治療薬
    • イベルメクチン

第8章 疥癬治療市場:地域別

  • 欧州 (ドイツ、フランス、イタリア、スペイン、ロシア、英国など)
  • アジア太平洋地域 (中国、日本、インド、韓国など)
  • 北米 (米国、カナダ、メキシコ)
  • 他の国々 (RoW) (ブラジルなど)

第9章 疥癬治療市場:市場変化の方向性

  • 事業拡張
  • 技術開発
  • 企業合併・買収 (M&A)、合弁事業
  • 供給契約

第10章 企業プロファイル

第11章 付録

目次

Scabies is an infectious skin disease caused by microscopic mites known as Sarcoptes scabiei, which are foud inside human skin. These Sarcoptes scabiei mites burrows into the skin and lay eggs after staying for two to three weeks. Scabies is diagnosed by an itchy feeling, rash and pimple like skin disease condition. Scabies is a highly contagious disease and can pass through simple contact with affected person. The disease is pruritic in nature. The common sites for the rash are wrist elbow, armpit, waist, area between the fingers. Globally increasing awareness and easing acess for treatments in major developing nations is expected drive the demand for scabies treatment during the period of study.

Geographically Asia-Pacific dominated scabies treatment market owing to the large population base which makes infectious diseases spread easily and less awareness amongst people about preventive measures for such diseases. Asia-Pacific was followed by Latin America and North America as second and third largest market for scabies treatment market. Asia Pacific is projected to have fastest growth, owing to rapidly increasing industrial healthcare infrastructure increasing awareness amongst people in the region especially in developing nations such as China, and India in this region.

This report identifies the global scabies treatment market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global scabies treatment market.

This report segments global scabies treatment market on the basis of drug administration route, medication type and regional market as follows:

Scabies Treatment Market research report is classified on the basis of drug administration route of scabies treatment some of the major types covered on the basis of administration are as follows: Oral and Topical

Scabies Treatment market research report is classified on the basis of medication type of scabies treatment some of the major types of scabies treatment covered in this report are as follows: Ointment (Gel, Creams and Lotions), Combinational medicines (Permethrin Cream, Benzyl Benzoate Lotion, Sulfur Ointment, Crotamiton Cream, Lindane Lotion) and Other medicine(Ivermectin)

This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the scabies treatment market. Some of the major companies' profiles in detail are as follows:

Renaissance Pharma Inc

Merck & Co.

Ranbaxy Laboratories Inc.,

Glaxo Smithkline Pharmaceuticals Ltd.

Unichem Laboratories Ltd

Table of Contents

1. Scabies Treatment Market - Market Overview

2. Executive Summary

3. Market Landscape

  • 3.1. Market Share Analysis
  • 3.2. Comparative Analysis
  • 3.3. Product Benchmarking
  • 3.4. End User Profiling
  • 3.5. Top 5 Financials Analysis

4. Scabies Treatment Market- Market Forces

  • 4.1. Drivers
    • 4.1.1. Increasing reported cases and awareness in the developing economies
  • 4.2. Restraints
  • 4.3. Opportunities
  • 4.4. Challenges
  • 4.5. Porter's Five Forces Analysis
    • 4.5.1. Bargaining Power of Suppliers
    • 4.5.2. Bargaining Power of Buyers
    • 4.5.3. Threat of New Entrants
    • 4.5.4. Threat of Substitutes
    • 4.5.5. Degree of Competition

5. Scabies Treatment Market- Strategic Analysis

  • 5.1. Value Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Opportunities Analysis
  • 5.4. Product/Market Life Cycle Analysis
  • 5.5. Suppliers and Distributors

6. Scabies Treatment Market, By Drug Administration Route

  • 6.1. Oral
  • 6.2. Topical

7. Scabies Treatment Market, By Medication Type

  • 7.1. Ointment
    • 7.1.1. Gel
    • 7.1.2. Creams
    • 7.1.3. Lotions
  • 7.2. Combinational medicines
    • 7.2.1. Permethrin Cream
    • 7.2.2. Benzyl Benzoate Lotion
    • 7.2.3. Sulfur Ointment
    • 7.2.4. Crotamiton Cream
    • 7.2.5. Lindane Lotion
  • 7.3. Other medicine
    • 7.3.1. Ivermectin

8. Scabies Treatment Market, By Geography

  • 8.1. Europe
    • 8.1.1. Germany
    • 8.1.2. France
    • 8.1.3. Italy
    • 8.1.4. Spain
    • 8.1.5. Russia
    • 8.1.6. U.K.
    • 8.1.7. Rest of Europe
  • 8.2. Asia Pacific
    • 8.2.1. China
    • 8.2.2. India
    • 8.2.3. Japan
    • 8.2.4. South Korea
    • 8.2.5. Rest of Asia-Pacific
  • 8.3. North America
    • 8.3.1. U.S.
    • 8.3.2. Canada
    • 8.3.3. Mexico
  • 8.4. Rest of the World (RoW)
    • 8.4.1. Brazil
    • 8.4.2. Rest of RoW

9. Scabies Treatment Market - Market Entropy

  • 9.1. Expansion
  • 9.2. Technological Developments
  • 9.3. Merger & Acquisitions, and Joint Ventures
  • 9.4. Supply- Contract

10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)

  • 10.1. Renaissance Pharma Inc
  • 10.2. Merck & Co.
  • 10.3. Ranbaxy Laboratories Inc.,
  • 10.4. Dr. Scabies
  • 10.5. Glaxo Smithkline Pharmaceuticals Ltd.
  • 10.6. Unichem Laboratories Ltd

More than 40 Companies are profiled in this Research Report, Complete List available on Request*

"*Financials would be provided on a best efforts basis for private companies"

11. Appendix

  • 11.1. Abbreviations
  • 11.2. Sources
  • 11.3. Research Methodology
  • 11.4. Bibliography
  • 11.5. Compilation of Expert Insights
  • 11.6. Disclaimer
Back to Top